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Introduction
Balanced reciprocal translocations are the most fre-
quent chromosome rearrangements in humans, occur-
ring in 0.16–0.20% (1/625–1/500) of live births [1–3].
A simple reciprocal translocation is produced when
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SUMMARY
Objective: To present perinatal findings, modes of ascertainment and parental decision in balanced reciprocal
translocations detected at amniocentesis.
Materials and Methods: Between January 1987 and August 2010, 82 cases with a simple reciprocal transloca-
tion, two cases with two separate simple reciprocal translocations and three cases with a complex chromosome
rearrangement (CCR) were diagnosed by amniocentesis at Mackay Memorial Hospital, Taipei, Taiwan. The 87
cases originated from 76 families; 65 families with one case and 11 families with two cases.
Results: In the 76 families, the main modes of ascertainment included advanced maternal age (n = 38), a previ-
ous child with an unbalanced reciprocal translocation (n = 11), recurrent miscarriage (n = 9), abnormal mater-
nal serum screening results (n = 9), elective causes (n = 5), a previous child with congenital anomalies (n = 2) and
abnormal ultrasound findings (n = 2). In these families, there were 17 (22.4%) de novo cases including 14 simple
translocations and three CCRs. Of 14 de novo cases with a simple translocation, one (7.1%) manifested a con-
genital malformation, which was related to an X-autosome translocation, and four (28.6%) were terminated.
Of three de novo CCRs, two manifested congenital anomalies and one was terminated. In 87 cases, additional
aneuploidy was noted in two cases including one inherited simple translocation with Turner syndrome, and one
de novo CCR with concomitant deletions and duplication.
Conclusion: Balanced reciprocal translocations detected at amniocentesis may be associated with fetal anom-
alies in cases of concomitant aneuploidy, de novo X-autosome translocation or de novo CCR. Genetic counseling
of a de novo simple reciprocal translocation at amniocentesis remains difficult because approximately one-
fourth of the parents opt for termination of the pregnancy, and detailed ultrasonography and array comparative
genomic hybridization are helpful for parental counseling under such circumstances. [Taiwan J Obstet Gynecol
2010;49(4):455–467]
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there is a two-way exchange between two chromosomes
in which two chromosomal segments from two chro-
mosomes break off, translocate, and unite. In addi-
tion to simple reciprocal translocations, there are rare
complex reciprocal translocations such as multiple
chromosome rearrangements (MCRs) and complex
chromosome rearrangements (CCRs). A MCR, or a dou-
ble chromosome rearrangement, is produced when there
are two separate simple translocations with double
two-way exchanges. A CCR is produced when there are
three or more breakpoints located on two or more
chromosomes [4]. The most common type of CCR is a
three-way exchange in which three chromosomal seg-
ments break off, translocate, and unite [5].
Amniocentesis may detect inherited or de novo bal-
anced reciprocal translocations. In cases with inherited
translocations, the parents may know their carrier sta-
tus prior to amniocentesis, or may be aware of their car-
rier status only after detection of fetal translocations at
amniocentesis. We present our experience of prenatal
diagnosis of balanced reciprocal translocations detected
at amniocentesis.
Materials and Methods
Between January 1987 and August 2010, balanced
reciprocal translocations were diagnosed by amnio-
centesis in 87 cases, including 82 cases with a simple
reciprocal translocation, two cases with two separate
simple reciprocal translocations of an MCR, and three
cases with a complex reciprocal translocation of a CCR
at Mackay Memorial Hospital, Taipei, Taiwan. Various
reasons for these findings included advanced maternal
age, abnormal ultrasound findings, abnormal maternal
serum screening results, a previous aneuploid child in the
obstetric history or in the family, and a family history
of congenital anomalies or chromosomal aberration,
among others. Cytogenetic analyses of parental blood
lymphocytes were performed in all cases. The clinical
data of the 87 cases are summarized in the Table.
Results
In this study, the 87 cases of balanced reciprocal translo-
cations originated from 76 families; 65 families with
one case and 11 families (families 4, 7, 21, 33, 38, 43,
44, 47, 50, 58 and 63) with two cases. Of these 87
cases, the mean gestational age at amniocentesis was
18.43 ± 2.97 weeks (range, 14–30 weeks) and the mean
maternal age at amniocentesis was 32.61 ± 4.22 years
(range, 20–40 years).
Among these 87 cases, there were three CCRs (cases
35, 61 and 76) (3.4%), two MCRs (cases 16 and 69;
2.3%) and 82 (94.3%) simple reciprocal translocations.
The three cases of CCRs arose de novo. Case 35 [t(5;
8;15)(q33.3;q11.21;q26.1)] was ascertained through
elective causes. The parents decided to continue the twin
pregnancy, which resulted in an abnormal co-twin (case
35) with a CCR, hypoplastic left heart, mitral stenosis
and neonatal death, and a normal co-twin with a normal
chromosome complement and a favorable outcome.
Case 61 [t(1;5;8)(p13;q14;p23.1)] was determined
through advanced maternal age. The parents decided
to continue the pregnancy, which resulted in a normal
child. Case 76 [t(2;18;14)(q33.1;q12.2;q31.2), dup(5)
(q34q34), del(7)(p21.1p21.1), del(10)(q25.3q25.3)]
was ascertained through abnormal maternal serum
screening results. The parents decided to terminate the
pregnancy, which resulted in an abnormal fetus with
multiple malformations. The two cases of MCRs were
concomitant de novo and inherited translocations. Case
16 [t(5;12)(q33;q13)dn t(11;22)(q23.3;q11.2)mat] was
determined through maternal carrier status identifica-
tion because of a previous aneuploid child. The parents
decided to continue the pregnancy, which resulted in a
normal child. Case 69 [t(7;11)(q22;p15)dn t(9;20)
(q21;p11.2)mat] was ascertained through advanced
maternal age. The mother was aware of her carrier status
only after the diagnosis, and the parents decided to con-
tinue the pregnancy, which resulted in a normal child.
Two cases (cases 49 and 76) were associated with
additional chromosomal aberration. Case 49 was asso-
ciated with Turner syndrome and cystic hygroma. Case
76 was associated with multiple deletions, a duplication
and dysmorphisms. Of the 87 cases with balanced recip-
rocal translocations, three (cases 35, 45 and 49; 3.4%)
were associated with abnormal ultrasound findings and
four (35, 45, 49 and 76; 4.6%) were associated with
congenital anomalies.
Among the 76 families, the main modes of ascertain-
ment included advanced maternal age (n = 38), parental
carrier status identified through a previous aneuploid
child with an unbalanced reciprocal translocation in
the obstetric history or in the family (n = 11), parental
carrier status identified through recurrent miscarriage
(n = 9), abnormal maternal serum screening results
(n = 9), elective causes (n = 5), a previous child with
structural anomalies or common aneuploidy (n = 2), and
abnormal ultrasound findings (n = 2). Of these families,
two (families 16 and 69; 2.6%) were associated with
concomitant de novo and inherited translocations, 15
(families 3, 6, 13, 14, 31, 35, 37, 41, 45, 53, 57, 61, 65,
68 and 76; 19.7%) were associated with only de novo
translocations, and 59 (77.6%) were associated with
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only inherited translocations. In the 17 families of de novo
translocations, the main modes of ascertainment in-
cluded advanced maternal age (n = 9), elective causes
(n = 4), abnormal maternal serum screening results
(n = 2), abnormal ultrasound findings (n = 1), and par-
ental carrier status identified through a previous aneu-
ploid child in the obstetric history or in the family (n = 1).
In the 61 families of inherited translocations, the main
modes of ascertainment included advanced maternal
age (n = 30), parental carrier status identified through
a previous aneuploid child with an unbalanced translo-
cation in the obstetric history or in the family (n = 11),
parental carrier status identified through recurrent mis-
carriage (n = 9), abnormal maternal serum screening
results (n = 7), a previous child with structural anomalies
or common aneuploidy (n = 2), elective causes (n = 1)
and abnormal ultrasound findings (n = 1).
Among these 61 families of inherited balanced
translocations, 20 (32.8%) had a known parental car-
rier status prior to the first amniocentesis due to a pre-
vious aneuploid child in the obstetric history or in the
family (n = 11), or parental carrier status identified
through recurrent miscarriage (n = 9), The other 41
(67.2%) families were aware of their parental carrier
status only after detection of fetal balanced reciprocal
translocation by amniocentesis for various reasons such
as advanced maternal age (n = 30), abnormal maternal
serum screening results (n = 7), a previous child with
structural anomalies or common aneuploidy (n = 2),
elective causes (n = 1) and abnormal ultrasound find-
ings (n = 1). For progeny with an alternate 2:2 segre-
gating reciprocal translocation in 61 couples of 61
inherited families, the parental female carrier/male
carrier ratio was 32/29.
Of the 17 de novo cases, five (cases 6, 31, 45, 68 and
76; 29.4%) were terminated, 12 (70.6%) were carried
to term, and three (cases 35, 45 and 76; 17.6%) mani-
fested congenital malformations. Of the 14 de novo cases
with a simple balanced reciprocal translocation, only
one case (case 45; 7.1%) manifested a congenital anom-
aly [t(X;7)(p11.2;q36)], which was associated with
congenital hydrocephalus and an X-autosome translo-
cation. In four (cases 6, 31, 45 and 68; 28.6%) of these
14 cases with three (cases 6, 31 and 68) without ultra-
sound abnormalities, the parents opted to terminate
the pregnancy following genetic counseling, and in 10
(71.4%) cases, the parents opted to continue the preg-
nancy following genetic counseling. Of the three (cases
35, 61 and 76) de novo cases with a CCR, two (cases 35
and 76) were associated with congenital anomalies and
one (case 76), which had additional chromosomal
aberration, was terminated. Of the two (cases 16 and
69) cases with an MCR and concomitant de novo and
inherited translocations, both were carried to term
with a normal outcome.
Discussion
In this study, the majority of balanced reciprocal translo-
cations detected at amniocentesis were ascertained
through advanced maternal age (50%, 38/76), a previ-
ous child with an unbalanced reciprocal translocation
in the obstetric history or in the family (14.5%, 11/76),
recurrent miscarriage (11.8%, 9/76) and abnormal ma-
ternal serum screening results (11.8%, 9/76). Our study
shows that inherited balanced reciprocal translocations
detected at amniocentesis are determined through re-
current miscarriage as often as through a previous child
with an unbalanced translocation (11.8% vs. 14.5%). In
contrast, inherited unbalanced structural chromosomal
abnormalities at prenatal diagnosis are rarely ascer-
tained through recurrent miscarriage [6]. Various reports
have shown that carrier couples ascertained through a
previous child with an unbalanced karyotype are at a
higher risk of unbalanced viable offspring than those
ascertained through recurrent miscarriage [7–10]. Since
the main indications for amniocentesis in the Taiwanese
population are advanced maternal age (∼50%) and
abnormal maternal serum screening results (∼25%)
[11–13], and balanced reciprocal translocations are
among the most frequent chromosome rearrangements
in humans, it is reasonable that the majority of bal-
anced reciprocal translocations detected at amniocen-
tesis in our study were ascertained through advanced
maternal age and abnormal maternal serum screening
results, in addition to a previous aneuploid child and
recurrent miscarriage.
Prenatal diagnosis of a balanced reciprocal translo-
cation may incidentally detect a balanced translocation
in the family. In this study, among the 61 families with
an inherited reciprocal translocation detected at amnio-
centesis, 67.2% (41/61) were aware of their parental
carrier status only after detection of fetal chromosomal
aberration by amniocentesis. The carriers of a balanced
reciprocal translocation are usually phenotypically nor-
mal because of a balanced complement of the genes.
A balanced reciprocal translocation can produce 32
different gametes, only two of which would result in a
normal complement or a balanced rearrangement by
the 2:2 alternate rearrangement [14]. Our study shows
that in the alternate 2:2 segregating reciprocal transloca-
tion, the parental male carriers have the same possibility
of balanced progeny as the female carriers, indicating
that there is little effect of alternate 2:2 segregation on
the fertility of the male carriers.
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Our results show that balanced reciprocal translo-
cations detected at amniocentesis are rarely associated
with abnormal ultrasound findings. This is in contrast to
unbalanced reciprocal translocations, which are fre-
quently associated with abnormal ultrasound abnor-
malities. In our study, among 87 prenatally detected
unbalanced reciprocal translocations, only 3.4% (3/87)
presented abnormal ultrasound findings, 4.6% (4/87)
manifested congenital anomalies, and the anomalous
cases were limited to those with concomitant aneuploidy,
de novo X-autosome translocation and de novo CCR.
Female carriers with a balanced X-autosome translo-
cation are generally phenotypically normal. However,
when there is predominant inactivation of the derivative
X chromosome or disruption of the genes at the break-
points, abnormal phenotypes may occur. In our study,
we observed a female fetus (case 45) with a de novo X-
autosome translocation of t(X;7)(p11.2;q36) and con-
genital hydrocephalus. The abnormal phenotype of this
case could be due to disruption of the genes at the
breakpoints on chromosomes Xp and/or 7q, or partial
functional disomy Xp (Xp11.2pter) and partial mono-
somy 7q (7q36qter) following predominant inactiva-
tion of the derivative X chromosome. Partial functional
disomy of Xp as a result of a balanced X-autosome
translocation is reportedly associated with phenotypic
abnormalities in females with a balanced X-autosome
translocation [15–18]. Disruption of the genes at the
breakpoints can also cause abnormal phenotypes. For
example, Lossi et al [19] reported abnormal expression
of the KLF8 gene due to disruption of the gene at the 
X chromosome breakpoint in a female patient with a
balanced X-autosome translocation of t(X;21)(p11.2;
q22.3) and non-syndromic mental retardation. Partial
monosomy 7q36qter may cause severe central ner-
vous system abnormalities. Genes at distal 7q such as
SHH at 7q36 [20], En2 at 7q36 [21] and HTR5A at
7q36.1 [22] are important for brain development. Male
carriers with a balanced X-autosome translocation are
likely to suffer from azoospermia because of a distur-
bance in spermatogenesis and a failure of most sper-
matocytes to enter into meiosis [23–26]. All de novo
balanced X-autosome translocations are of paternal
origin and once a balanced X-autosome translocation
with phenotypic normality is established in the family,
the transmission will be matrilineal since male infertility
makes being patrilineal impossible [5].
In this study, two of three fetuses with a de novo
apparently balanced CCR were associated with pheno-
typic abnormalities. In a review of 18 cases of prena-
tally ascertained de novo apparently balanced CCRs
and MCRs, Chen et al [27] reported that 55.6%
(10/18) manifested phenotypic abnormalities. It has
been reported that de novo apparently balanced CCRs
probably have a high risk for abnormal phenotypes,
and the risk increases with the numbers of breakpoints
[28,29]. The CCRs may cause reproductive failure, mul-
tiple miscarriage, stillbirths, mental retardation, dys-
morphism and congenital malformations, and such
CCRs may involve an unexpected level of complexity with
imbalance at or near the breakpoints or in other chro-
mosomes. Currently, precise definitions of CCRs can be
made, and their complexity can be elucidated by means
of molecular cytogenetic technologies such as fluores-
cence in situ hybridization and array comparative genomic
hybridization (aCGH) [30–37]. Most de novo CCRs are
of paternal origin [38,39], and most familial CCRs are
of maternal origin and usually have three to four break-
points [29,39]. CCRs arise during spermatogenesis and
are preferentially transmitted through oogenesis in
families [39].
Structural chromosome rearrangements are usually
familial (80%), but they may arise de novo [3]. Olson
and Magenis [40] reported that 84.4% (27/32) of cases
with a de novo structural chromosome rearrangement
were paternal in origin. Seventeen of 76 families (22.4%)
in our study were associated with de novo balanced
reciprocal translocations including three de novo CCRs
and 14 de novo simple balanced reciprocal transloca-
tions. In our study, 7.1% (1/14) of de novo simple bal-
anced reciprocal translocations manifested a congenital
anomaly, and the anomalous case was related to an X-
autosome translocation. Warburton [41] reported that
the risk of a serious congenital anomaly was 6.1% (10/
163) for prenatally detected de novo balanced recipro-
cal translocations. The abnormal cases in their report
also included a case with X-autosome translocation of
46,X,t(X;4)(p21;q35). Warburton [41] reported a ter-
mination rate of 24% for de novo balanced reciprocal
translocations detected at prenatal diagnosis. In our
study, 28.6% (4/14) of the cases with a de novo simple
balanced reciprocal translocation were terminated
owing to the parents’ decision following counseling for
the risk of abnormalities with a de novo rearrangement.
Gardner and Sutherland [5] suggested that in prena-
tally detected de novo simple balanced reciprocal translo-
cations, the risk for abnormalities may comprise 3% for
the background risk, 3% for the chromosome defect risk
and an additional 1% for the overall risk for both major
malformations and functional deficits.
In summary, we have presented perinatal findings,
the modes of ascertainment and the parental decision
of balanced reciprocal translocations detected at amnio-
centesis. Balanced reciprocal translocations detected at
amniocentesis may be associated with fetal anomalies
in cases of concomitant common aneuploidy, de novo
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A
B Chromosome 3
Chromosome 6
Figure 1. A case (case 3) with a de novo balanced simple reciprocal translocation. (A) A karyotype of 46,XY,t(3;6)(q26.2;
p21.2)dn. The arrows indicate the breakpoints. dn = de novo. (B) Oligonucleotide-based array comparative genomic hybridization
using Oligo HD Scan (CMDX, Irvine, CA, USA) shows no loss or increase in the dosage of genetic probes specific for chromo-
somes 3 and 6.
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Figure 2. A case (case 45) with a de novo X-autosome translocation, hydrocephalus and a karyotype of 46,X,t(X;7)(p11.2;q36)dn.
The arrows indicate the breakpoints.
Figure 3. A case (case 49) with concomitant Turner syndrome, an inherited simple reciprocal translocation, cystic hygroma
and a karyotype of 45,X,t(2;3)(q13;q26.2)mat. The arrows indicate the breakpoints. mat = maternal.
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Figure 4. A case (case 16) with a multiple chromosome rearrangement consisting of two separate simple reciprocal translo-
cations (de novo and inherited) and a karyotype of 46,XY,t(5;12)(q33;q13)dn t(11;22)(q23.3;q11.2)mat. The arrows indicate
the breakpoints.
Figure 5. A case (case 35) with a de novo complex chromosome rearrangement with three breakpoints and a karyotype of
46,XX,t(5;8;15)(q33.3;q11.21;q26.1)dn, 1qh+ mat. The arrows indicate the breakpoints.
X-autosome translocation, or de novo CCR. Genetic
counseling for a de novo simple reciprocal translocation
at amniocentesis remains difficult because approxi-
mately one fourth of the parents opt for termination
of the pregnancy, and detailed ultrasonography and
aCGH are helpful for parental counseling under such
circumstances.
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